Analysis of polymorphisms of TNF-α, LT-α, IL-10, IL-12 and CTLA-4 in patients with warm autoimmune haemolytic anaemia.

Abstract:

INTRODUCTION:Autoimmune haemolytic anaemia (AIHA) is defined as the increased destruction of red blood cells (RBCs) in the presence of anti-RBC autoantibodies and/or complement. Its pathogenesis is multifactorial and includes changes in mechanisms of cytokine production and functionality. A number of recent studies have implicated cytokines polymorphisms in the pathogenesis of autoimmune diseases. The aim of this study was to determine the frequency of polymorphisms of tumour necrosis factor alpha (TNF-α), lymphotoxin-α (LT-α), interleukin 10 (IL-10), interleukin 12 (IL-12) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in patients with AIHA in comparison with healthy individuals. METHODS:The study population consisted of 17 patients with AIHA and 40 healthy controls. The polymorphisms for TNF-α-308, LT-α +252, IL-10 -592, IL-12 +1188 and CTLA-4 +49 were examined by polymerase chain reaction followed by specific restriction enzyme digestion. RESULTS:There was no significant difference in the phenotypic distributions of polymorphisms of the TNF-α, IL-10, IL-12 and CTLA-4 between the patients and controls. Compared with healthy controls, patients with AIHA had a significant higher frequency of LT-α (+252) AG phenotype (41%vs. 13%; P = 0.032). CONCLUSION:In this study, no significant differences on the frequency of TNF-α, IL-10, IL-12 and CTLA-4 polymorphisms between patients with AIHA and controls was found, suggesting that the targeted polymorphisms do not influence on the emergence and evolution of the disease. However, the LT-α +252 polymorphism might have an effect for AIHAI development, suggesting that further studies are necessary to clear up this question.

journal_name

Int J Lab Hematol

authors

D'Abronzo LS,Barros MM,Bordin JO,Figueiredo MS

doi

10.1111/j.1751-553X.2012.01400.x

subject

Has Abstract

pub_date

2012-08-01 00:00:00

pages

356-61

issue

4

eissn

1751-5521

issn

1751-553X

journal_volume

34

pub_type

杂志文章
  • Performance evaluation of the Sysmex(®) XP-300 in an oncology setting: evaluation and comparison of hematological parameters with the Sysmex(®) XN-3000.

    abstract:INTRODUCTION:The Sysmex XP-300(®) (XP-300) is a new, fully automated hematology analyzer, designed to generate complete blood counts (CBC) with 3-part differential. In our study, the XP-300 was evaluated as a point-of-care (POC) analyzer in an oncology setting. In which blood samples from patients with different pathol...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/ijlh.12522

    authors: van Dievoet MA,Louagie H,Ghys T

    更新日期:2016-10-01 00:00:00

  • A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.

    abstract:INTRODUCTION:While the presence of disseminated intravascular coagulation (DIC) has been implicated in worse clinical outcome in acute leukemia, the relationship between different subtypes of acute leukemia and the clinicopathologic features of DIC has not been systematically well studied. METHODS:In this study, we re...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.12636

    authors: Shahmarvand N,Oak JS,Cascio MJ,Alcasid M,Goodman E,Medeiros BC,Arber DA,Zehnder JL,Ohgami RS

    更新日期:2017-08-01 00:00:00

  • Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors.

    abstract::Though not very common, solid tumor involvement of the bone marrow (BM) may have serious consequences. Recent studies have shown that mean platelet volume (MPV) is a good indicator for BM disease in the differential diagnosis of thrombocytopenia. We investigated the significance of MPV in the diagnosis of BM metastasi...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2007.00947.x

    authors: Aksoy S,Kilickap S,Hayran M,Harputluoglu H,Koca E,Dede DS,Erman M,Turker A

    更新日期:2008-06-01 00:00:00

  • Clinical and hematological characteristics of 88 patients with COVID-19.

    abstract:INTRODUCTION:To retrospectively analyze epidemiological, clinical and hematological characteristics of COVID-19 patients. METHODS:The demographic, symptoms, and physiological parameters of 88 patients were collected and analyzed. The performance of complete blood count (CBC) indexes for monitoring and predicting the s...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.13291

    authors: Zhang H,Cao X,Kong M,Mao X,Huang L,He P,Pan S,Li J,Lu Z

    更新日期:2020-12-01 00:00:00

  • Red blood cell morphology.

    abstract::The foundation of laboratory hematologic diagnosis is the complete blood count and review of the peripheral smear. In patients with anemia, the peripheral smear permits interpretation of diagnostically significant red blood cell (RBC) findings. These include assessment of RBC shape, size, color, inclusions, and arrang...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章,评审

    doi:10.1111/ijlh.12082

    authors: Ford J

    更新日期:2013-06-01 00:00:00

  • Hematopoietic stem cell lodgment in the adult bone marrow stem cell niche.

    abstract::Treatment of malignant blood disorders, such as leukemia, that can provide a better chance of long-term remission involves myeloablation followed by transplantation of matched donor hematopoietic stem cells (HSCs). For successful engraftment and re-establishment of hematopoiesis to occur in the recipient, the transpla...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1751-553X.2010.01250.x

    authors: Lam BS,Adams GB

    更新日期:2010-12-01 00:00:00

  • Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.

    abstract:INTRODUCTION:In the cytogenetically normal population of AML (CN-AML), FLT3-ITD-positive and wild-type NPM1 is correlated with a worse outcome, and FLT3-ITD-negative with NPM1-mut is correlated with a better outcome. This leaves a large subpopulation of CN-AML patients without NPM1 or FLT3-ITD mutations with heterogene...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.12649

    authors: Guo RJ,Atenafu EG,Schimmer AD,Minden MD,Chang H

    更新日期:2017-08-01 00:00:00

  • Nontransferrin-bound iron in transfused patients with sickle cell disease.

    abstract::The value of nontransferrin-bound iron (NTBI) as an index of iron overload in patients with thalassemia has been evaluated; however, data in patients with sickle cell disease (SCD) is limited. NTBI levels were evaluated in a cross-sectional study of 43 transfused patients with SCD. Patient charts were reviewed for dem...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2010.01224.x

    authors: Inati A,Musallam KM,Cappellini MD,Duca L,Taher AT

    更新日期:2011-04-01 00:00:00

  • Accuracy of serum transferrin receptor levels in the diagnosis of iron deficiency among hospital patients in a population with a high prevalence of thalassaemia trait.

    abstract::The diagnosis of iron deficiency in hospital patients can be difficult in the presence of inflammation. A raised serum transferrin receptor (sTfR) level is useful as a marker of iron deficiency as it is unaffected by inflammation. However, diseases that cause an increase in erythropoietic activity can also result in a...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2007.00982.x

    authors: Ong KH,Tan HL,Tam LP,Hawkins RC,Kuperan P

    更新日期:2008-12-01 00:00:00

  • Performance evaluation of the new hematology analyzer Sysmex XN-series.

    abstract:INTRODUCTION:The Sysmex XN-series is a new automated hematology analyzer designed to improve the accuracy of cell counts and the specificity of the flagging events. METHODS:The basic characteristics and the performance of new measurement channels of the XN were evaluated and compared with the Sysmex XE-2100 and the ma...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.12254

    authors: Seo JY,Lee ST,Kim SH

    更新日期:2015-04-01 00:00:00

  • International Council for Standardization in Haematology (ICSH) laboratory guidance for the evaluation of haemostasis analyser-reagent test systems. Part 1: Instrument-specific issues and commonly used coagulation screening tests.

    abstract::Before a new method is used for clinical testing, it is essential that it is evaluated for suitability for its intended purpose. This document gives guidance for the performance of verification, validation and implementation processes required by regulatory and accreditation bodies. It covers the planning and executio...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章,评审

    doi:10.1111/ijlh.13411

    authors: Gardiner C,Coleman R,de Maat MPM,Dorgalaleh A,Echenagucia M,Gosselin RC,Ieko M,Kitchen S

    更新日期:2020-11-29 00:00:00

  • A ten-color tube with dried antibody reagents for the screening of hematological malignancies.

    abstract:INTRODUCTION:The workflow in clinical flow cytometry laboratories must constantly be reviewed to develop technical procedures that improve quality and productivity and reduce costs. Using the Beckman Coulter dry coating technology, we customized a ten-color tube with dried antibody reagents, designated the Duraclone sc...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.12753

    authors: Correia RP,Rajab A,Bento LC,Alexandre AM,Vaz AC,Schimidell D,Pedro EC,Perin FS,Nozawa ST,Barroso RS,Bacal NS

    更新日期:2018-04-01 00:00:00

  • Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.

    abstract:INTRODUCTION:To study the effect of bortezomib alone or in combination with daunorubicin (DNR) on an mdr1 single-factor drug-resistant leukemia cell line K562/MDR1, a multifactor-resistant cell line K562/A02, a drug-sensitive cell line K562, and primary cells from acute myeloid leukemia patients. METHODS:The cell line...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2011.01384.x

    authors: Zheng B,Zhou R,Gong Y,Yang X,Shan Q

    更新日期:2012-06-01 00:00:00

  • MFI ratio estimation of ZAP-70 in B-CLL by flow cytometry can be improved by considering the isotype-matched antibody signal.

    abstract:INTRODUCTION:The IgV(H) mutational status of B-cell chronic lymphocytic leukemia (B-CLL) is of prognostic value. Expression of ZAP-70 in B-CLL is a surrogate marker for IgV(H) unmutated (UM). As determination of IgV(H) mutational status involves a methodology currently unavailable for most clinical laboratories, it is ...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2010.01263.x

    authors: Marquez ME,Deglesne PA,Suarez G,Romano E

    更新日期:2011-04-01 00:00:00

  • Association of Janus kinase 2 (JAK2) polymorphisms with acute leukemia susceptibility.

    abstract:INTRODUCTION:Aberrant activation of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway leads to deregulated proliferation, differentiation, or apoptosis of normal cells. One of the members of this family, JAK2, plays a very important role in metabolizing carcinogens and medications. This...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2011.01386.x

    authors: Zhong Y,Wu J,Ma R,Cao H,Wang Z,Ding J,Cheng L,Feng J,Chen B

    更新日期:2012-06-01 00:00:00

  • Evaluation of the leukocyte differential on a new automated flow cytometry hematology analyzer.

    abstract:INTRODUCTION:The Hematoflow (Beckman Coulter, USA) is a new automated hematology analyzer, which provides a 16-part white blood cell count (WBC) differential. METHODS:We evaluated the differential WBC count performance of the Hematoflow. 101 blood samples from patients were selected for comparison analysis. RESULTS:T...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2012.01432.x

    authors: Kim JE,Kim BR,Woo KS,Han JY

    更新日期:2012-10-01 00:00:00

  • A rare case of Lennert's type peripheral T-cell lymphoma with t(14;19)(q11.2;q13.3).

    abstract::Although most patients with peripheral T-cell lymphoma (PTCL) show clonal rearrangement of T-cell receptor genes, few PTCLs show recurrent chromosomal abnormalities. We describe here a rare chromosomal rearrangement, t(14;19)(q11.2;q13.3), in a Lennert's lymphoma, a variant of PTCL, not otherwise specified. Sequential...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2011.01385.x

    authors: Shin SY,Jang S,Park CJ,Chi HS,Lee KH,Huh J,Seo EJ

    更新日期:2012-06-01 00:00:00

  • Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

    abstract:INTRODUCTION:Gene expression profiling (GEP) risk models in multiple myeloma are based on 3'-end microarrays. We hypothesized that GEP risk signatures could retain prognostic power despite being translated and applied to whole-transcript microarray data. METHODS:We studied CD138-positive bone marrow plasma cells in a ...

    journal_title:International journal of laboratory hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1111/ijlh.12486

    authors: Hermansen NE,Borup R,Andersen MK,Vangsted AJ,Clausen NT,Kristensen DL,Nielsen FC,Gimsing P

    更新日期:2016-06-01 00:00:00

  • High-throughput on-chip leukemia diagnosis.

    abstract::Advances in lab-on-a-chip technologies enabled programmable, reconfigurable, and scalable manipulation of a variety of laboratory procedures. Samples, reagents, and fluids can be precisely controlled; buffer temperature, pH, and concentration control systems as well as a variety of detection systems can be integrated ...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章,评审

    doi:10.1111/ijlh.12054

    authors: Park S,Moon HS,Lee DS,Kim HC,Chun H

    更新日期:2013-10-01 00:00:00

  • Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.

    abstract:INTRODUCTION:Multiple types of mutations in the BCR-ABL1 kinase domain have been reported. We previously reported a common alternatively spliced BCR-ABL mRNA with a 35-nucleotide insertion (35INS). We report three novel alternative splicing mutants expressed as the dominant transcripts in patient with chronic myelogeno...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2010.01291.x

    authors: Ma W,Giles F,Zhang X,Wang X,Zhang Z,Lee TS,Yeh CH,Albitar M

    更新日期:2011-06-01 00:00:00

  • The automation of routine light transmission platelet aggregation.

    abstract:INTRODUCTION:The investigation of platelet function by aggregometry requires specialist equipment and is labour intensive. We have developed an automated platelet aggregation method on a routine coagulation analyser. METHODS:We used a CS-2000i (Sysmex) with prototype software to perform aggregation in platelet-rich pl...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.12161

    authors: Lawrie AS,Kobayashi K,Lane PJ,Mackie IJ,Machin SJ

    更新日期:2014-08-01 00:00:00

  • Evaluation of the HemoCue WBC DIFF in leukopenic patient samples.

    abstract:BACKGROUND:White blood cell (WBC) counts are used to monitor bone marrow function and to screen for infections. The HemoCue WBC DIFF Point-Of-Care (POC) instrument classifies WBCs through cell image recognition. To evaluate its suitability for monitoring cancer patients, we examined its performance in samples from pati...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.13158

    authors: Kur DK,Agersnap N,Holländer NH,Pedersen OBV,Friis-Hansen L

    更新日期:2020-06-01 00:00:00

  • Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.

    abstract::Bone marrow BCR-ABL transcript levels were monitored serially by real-time quantitative PCR in 46 imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response (CCyR) for a median of 42 months (range: 9-53). Of 41 patients in continuous CCyR, 32 and nine could achieve a >/=3-log (MMo...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2007.00962.x

    authors: Qin YZ,Liu YR,Zhu HH,Li JL,Ruan GR,Zhang Y,Jiang Q,Jiang H,Li LD,Chang Y,Huang XJ,Chen SS

    更新日期:2008-08-01 00:00:00

  • Use of a capillary specimen in the laboratory to verify a point-of-care international normalized ratio: Avoidance of a venipuncture in a pediatric setting.

    abstract:INTRODUCTION:Point-of-care (POC) international normalized ratio (INR) values above an institutional cutoff are confirmed in the laboratory using a gold standard venous specimen. This can be problematic in a pediatric setting. METHOD:In this study, 449 consecutive POC INR results were compared to an INR performed in th...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.12920

    authors: Williams VK

    更新日期:2019-02-01 00:00:00

  • Assessing nonvitamin K antagonist oral anticoagulants (NOACs) in the laboratory.

    abstract::Nonvitamin K antagonist oral anticoagulants (NOACs) are being used with increasing frequency due to their safety profile, ease of use, and given that therapeutic monitoring is not required. As these agents have only recently been FDA approved, their effect on routine and specialty coagulation assays is not well apprec...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章,评审

    doi:10.1111/ijlh.12350

    authors: Gosselin RC,Adcock DM

    更新日期:2015-05-01 00:00:00

  • Analytical comparison between two hematological analyzer systems: CAL-8000 vs. XN-9000.

    abstract:INTRODUCTION:This study was aimed to compare the analytical performance of traditional and new parameters and morphological flags of CAL-8000 and XN-9000. The automated differential leukocyte count (DIFF profile) and morphological flags were compared with optical microscopy (OM). METHODS:A total of 1025 peripheral blo...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/ijlh.12597

    authors: Buoro S,Mecca T,Seghezzi M,Manenti B,Azzarà G,Dominoni P,Crippa A,Ottomano C,Lippi G

    更新日期:2017-04-01 00:00:00

  • ICSH recommendations for the measurement of haemoglobin F.

    abstract::Measurement of the Haemoglobin F in red cell haemolysates is important in the diagnosis of δβ thalassaemia, hereditary persistence of fetal haemoglobin (HPFH) and in the diagnosis and management of sickle cell disease. The distribution of Hb F in red cells is useful in the diagnosis of HPFH and in the assessment of fe...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章,实务指引

    doi:10.1111/j.1751-553X.2011.01367.x

    authors: Stephens AD,Angastiniotis M,Baysal E,Chan V,Davis B,Fucharoen S,Giordano PC,Hoyer JD,Mosca A,Wild B,International Council for The Standardisation of Haematology (ICSH).

    更新日期:2012-02-01 00:00:00

  • Guidance for storing blood samples in laboratories performing complete blood count with differential.

    abstract:INTRODUCTION:The complete blood count (CBC) with differential leukocyte count (DIFF) is an important part of clinical laboratory analyses and provides crucial data for clinicians. Delivery time after blood collection and conditions of storage is known to affect the reliability of results of some hematologic parameters....

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2012.01452.x

    authors: Cornet E,Behier C,Troussard X

    更新日期:2012-12-01 00:00:00

  • The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation.

    abstract::Prediction of the timing of platelet recovery after chemotherapy and hematopoietic stem cell transplantation (HSCT) allows for optimal platelet transfusion. We assessed the clinical utility of the percentage value of the immature platelet fraction (IPF%) monitored using an XE-2100 automated hematology analyzer to pred...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2010.01232.x

    authors: Yamaoka G,Kubota Y,Nomura T,Inage T,Arai T,Kitanaka A,Saigo K,Iseki K,Baba N,Taminato T

    更新日期:2010-12-01 00:00:00

  • Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients.

    abstract::Molecular monitoring of the BCR-ABL1 transcript in chronic myelogenous leukemia (CML) using quantitative real-time PCR (RQ-PCR) can be performed using either bone marrow (BM) or peripheral blood (PB). However, a recent report by Stock et al. [International Journal of Oncology 28 (2006) 1099] questioned the reliability...

    journal_title:International journal of laboratory hematology

    pub_type: 杂志文章

    doi:10.1111/j.1751-553X.2009.01198.x

    authors: Ballestrero A,Cirmena G,Dominietto A,Garuti A,Rocco I,Cea M,Moran E,Nencioni A,Miglino M,Raiola AM,Bacigalupo A,Patrone F

    更新日期:2010-08-01 00:00:00